JAMIE RILES: Open Payments
NPI 1780097691 · ELIZABETHTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$693 in 41 payments from 7 companies in 2025. Trend: 2023 $85 · 2024 $200 · 2025 $693
Food & beverage: $693
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $268 |
| Indivior Inc. | 8 | $157 |
| Gilead Sciences, Inc. | 5 | $97 |
| Braeburn Inc. | 4 | $60 |
| Alkermes, Inc. | 2 | $50 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
Products named: SUBLOCADE, MAVYRET, VRAYLAR, BRIXADI, Auvelity, VIVITROL, REXULTI, LYBALVI.
Industry payments across KY — which companies pay providers there.
